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Background: Histone post-translational modifications (PTMs) are key epigenetic regulators in chromatin-based
processes. Increasing evidence suggests that vast combinations of PTMs exist within chromatin histones. These
complex patterns, rather than individual PTMs, are thought to define functional chromatin states. However, the
ability to interrogate combinatorial histone PTM patterns at the nucleosome level has been limited by the lack
of direct molecular tools.
Results: Here we demonstrate an efficient, quantitative, antibody-free, chromatin immunoprecipitation-less
(ChIP-less) method for interrogating diverse epigenetic states. At the heart of the workflow are recombinant
chromatin reader domains, which target distinct chromatin states with combinatorial PTM patterns. Utilizing a
newly designed combinatorial histone peptide microarray, we showed that three reader domains (ATRX-ADD,
ING2-PHD and AIRE-PHD) displayed greater specificity towards combinatorial PTM patterns than corresponding
commercial histone antibodies. Such specific recognitions were employed to develop a chromatin reader-based
affinity enrichment platform (matrix-assisted reader chromatin capture, or MARCC). We successfully applied the
reader-based platform to capture unique chromatin states, which were quantitatively profiled by mass spectrometry
to reveal interconnections between nucleosomal histone PTMs. Specifically, a highly enriched signature that
harbored H3K4me0, H3K9me2/3, H3K79me0 and H4K20me2/3 within the same nucleosome was identified from
chromatin enriched by ATRX-ADD. This newly reported PTM combination was enriched in heterochromatin, as
revealed by the associated DNA.
Conclusions: Our results suggest the broad utility of recombinant reader domains as an enrichment tool specific
to combinatorial PTM patterns, which are difficult to probe directly by antibody-based approaches. The reader
affinity platform is compatible with several downstream analyses to investigate the physical coexistence of
nucleosomal PTM states associated with specific genomic loci. Collectively, the reader-based workflow will
greatly facilitate our understanding of how distinct chromatin states and reader domains function in gene
regulatory mechanisms.
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Post-translational modifications (PTMs) on histones con-
stitute an intricate ‘language’ that instructs chromatin-
based processes [1]. Different histone PTMs deposited
across multiple residues on histone proteins generate a
combinatorial pattern. The number of combinations can
be further amplified by the presence of two copies of each* Correspondence: jmdenu@wisc.edu
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unless otherwise stated.histone (H3, H4, H2A and H2B) within a nucleosome.
One intriguing hypothesis is that PTM combinations better
categorize unique chromatin states than an assessment
of an individual PTM. Evidence of the importance of
combinatorial PTMs comes from studies on embryonic
stem cells, where the coexistence of ‘active mark’
H3K4me3 and ‘repressive mark’ H3K27me3 at differenti-
ation-related gene promoters poises genes for subsequent
regulation [2]. Also, the coexistence of H3S10ph and
H3K9me3 is a signal to evict heterochromatin protein 1
during the M phase [3]. How combinatorial PTM patterns
reflect specific chromatin states or biological processesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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combinatorial capacity of PTM patterns [4,5] has been
hindered by a lack of proper tools to distinguish different
combinatorial PTM patterns.
Current methodologies to define chromatin states rely
almost exclusively on histone antibodies, which have
been developed to recognize individual PTMs. As sum-
marized in Table 1, each of these approaches has its own
limitations for analysis of the combinatorial histone
PTM patterns. Proper interpretation of such analyses
relies on a thorough understanding of the specificity of
these antibodies. However, recent studies reveal cross-
reactivity to unexpected antigens (‘off-targets’) of many
commercial histone antibodies [6-11]. Lot-to-lot varia-
bility, high costs and engineering difficulties are critical
concerns for the development and commercialization of
histone antibodies [12,13]. All these have challenged the
use of histone antibodies in accurately probing chro-
matin states. Therefore an antibody-free approach to
directly enrich combinatorial PTM patterns that main-
tains native nucleosome structure and combinatorial
PTM complexity for downstream quantitation and
genome mapping of physical intranucleosomal PTM
connections will greatly simplify attempts to characterize
chromatin states.
To address this bottleneck, we developed an epigenetic
platform utilizing ‘reader’ domains to enrich, identify
and quantify chromatin states. Reader domains are a
diverse collection of histone-interacting protein modules
that can interpret histone PTM language in cells [23].
Previously, we and other groups described the ability
of reader domains to discriminate combinatorial PTM
patterns [24,25], suggesting their potential for probing
native chromatin states. Using three readers as proof
of concept, we demonstrated a powerful workflow in-
volving a combinatorial PTM histone peptide microarray
and a reader-based affinity enrichment platform (matrix-
assisted reader chromatin capture, or MARCC) to capture
and quantify chromatin states maintained on native






















✔ ✔ (within one
histone tail)Results and discussion
The chromatin affinity enrichment requires highly spe-
cific ‘baits’ that can distinguish different PTM states,
making readers such as malignant brain tumor domains
unsuitable for such application due to their insensitivity
to residues surrounding the targeted methyl lysine group
[26]. Three reader domains were selected (Additional file 1:
Figure S1) based on their reported chromatin-binding
specificities: plant homeodomain (PHD) zinc fingers
from ING2 and AIRE, and the ADD (ATRX-DNMT3A-
DNMT3L) domain from ATRX [27-32]. To evaluate the
specificity of reader domains systematically, we designed
a histone peptide library that featured a more comprehen-
sive collection of histone peptides than previous platforms
[6,7] (compared in Table 2). The new library contained
746 tiled peptide species, ≈60% of which comprised new
PTMs or novel combinations (Figure 1A and Additional
file 2). Such extensive PTM combinations were critical in
evaluating the effects of combinatorial PTM patterns on
reader binding specificity.
Reader domains were recombinantly expressed and
purified as HaloTag fusions, which permitted sensitive
detection by covalent labeling with fluorescence [36]
when screened on microarrays containing ≈ 4,500 peptides
(Figure 1B). An additional fluorescence dye was intro-
duced during peptide printing to enable dual-channel
fluorescence detection (532 nm/635 nm) and allowing
easy identification of misprinting (Figure 1C). Binding
events were quantified from fluorescence signal intensities
at 635 nm of spatially addressed peptides. Each peptide
was printed six times on each microarray for statistical
analysis and proper control peptides were included in each
subarray (Figure 1C). For comparison, two ChIP-grade
commercial antibodies for H3K9me3 and H3K4me3 were
analyzed using the microarrays.
Microarray analysis revealed high selectivity for amino-
acid sequence and combinatorial PTM states with reader
domains (for complete dataset, see Additional file 3).
Sequence specificity was assessed by comparing binding
















Table 2 Comparison between different platforms of histone peptide microarrays
Platforms Combinatorial PTM histone peptide
microarray (this report)
MODified histone peptide array
(Active Motif) [7,33]
EpiGOLD histone peptide array
(EpiCypher) [6,34,35]
Array coating Nitrocellulose Nitrocellulose Streptavidin
Peptide coverage Single PTMs 169 peptides covering 61 sites
of H3, H4, H2A and H2B
70 peptides covering 37 sites of
H3, H4, H2A and H2B (N-term)
70 peptides covering 28 sites
of H3, H4, H2A and H2B
Combinatorial
PTMs
371 peptides containing up to 5 PTMs 309 peptides containing up
to 4 PTMs
121 peptides containing up
to 5 PTMs
Histone variants 134 peptides of H3, H4, H2A, H2B
and H1 variants
— 4 peptides of H2A.X




Tiled sequence ✔ ✔ -
Spot replicates 3 spots × 2 subarrays 1 spot × 2 subarrays 6 spots × 4 subarrays
Dual-channel detection ✔ - ✔
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and Additional file 5: Figure S3). ATRX-ADD, AIRE-PHD
and ING2-PHD bound three different PTM states,
H3K9me3, H3K4unmod and H3K4me3, respectively, with
no evident off-targets. By contrast, the two antibodies
exhibited unsatisfactory sequence specificities. Most not-
ably, there was dramatic off-target binding to H3K79me3
peptide using the H3K9me3 antibody (ab8898) and unex-
pected binding to H3K18me3 using the H3K4me3 anti-
body (ab8580) (Figure 2A and Additional file 5: Figure S3).
Such cross-reactivity of histone antibodies at multiple sites
is particularly concerning because the biological functions
of histone PTMs are site-dependent and therefore con-
found the interpretation of antibody-dependent data.
Collectively, our binding results further underscore speci-
ficity issues with histone antibodies and highlight the high
specificity of the tested reader domains.
Within the same amino-acid sequence, the combina-
torial PTM pattern is an important component of the
chromatin landscape, and an appropriate enrichment
strategy should select among diverse PTM states. Binding
signals resulting from the same sequence were extracted
from the microarray and the effects on coexisting (com-
binatorial) modifications in the H3 tail were assessed
(Figure 2B). Modifications at R2 and T3 diminished
binding of AIRE-PHD and ING2-PHD to the H3 tail
(Figure 2B). For ATRX-ADD, K9me3 binding was abro-
gated by modifications at T3, T6 and R8 (Figure 2B). Most
importantly, ATRX-ADD but not the antibody ab8898 dis-
criminated against the bivalent peptide H3K4me3K9me3
(Figure 2B), suggesting that ATRX-ADD can uniquely
enrich K4me0K9me3-containing chromatin. The strict
specificity for K9me3 within the proper surrounding PTM
state and a correct N-terminal context (Figure 2B and
Additional file 5: Figure S3) can be explained by the
extensive interactions of ATRX-ADD with H3 1-10aa
[27,28]. By comparison, the antibodies were less affectedby surrounding residues and PTMs, failing to distinguish
different PTM combinations (Figure 2B). We reasoned
that the recognition specificity is largely dependent on the
contact surface between the binding module (readers or
antibodies) and its histone target. Reader modules with
more surface interaction with the histone molecules, as
we have shown here with ATRX-ADD, ING2-PHD,
AIRE-PHD, will have longer sequence discrimination
and therefore greater sensitivity to combinatorial PTMs
within those contacts. For example, the linked domains of
ATRX-ADD revealed increased binding specificity that
results from the larger interaction surface with histone
substrates (Figure 2).
Previous studies have demonstrated that reader
domains interact with preferred histone substrates at low
micromolar affinity [27-32], a range equal to or weaker
than antibody recognition, which varies from micromolar
to nanomolar [11]. To test whether such micromolar
affinity is adequate for enriching specific nucleosomal
PTMs, we next assessed the ability of ATRX-ADD to
discriminate PTMs on a folded nucleosome structure,
consisting of reconstituted mononucleosomes bearing
either H3Kc4me3 or H3Kc9me3 (chemical analogs of
H3K4me3 and H3K9me3 that permit stoichiometric modi-
fication). Consistent with the peptide microarray analysis,
ATRX-ADD only exhibited binding with H3Kc9me3-
containing nucleosomes (Additional file 6: Figure S4).
Furthermore, using standard Western blotting protocols,
we demonstrate that ATRX-ADD can function as a highly
specific probe to detect endogenous H3K9me3 from cell
lysate, showing sufficient affinity and specificity that rivals
the corresponding antibody (Additional file 7: Figure S5).
We then evaluated whether the immobilized reader
domains (MARCC approach) (Figure 3) captured unique
chromatin states in native mononucleosomes from MCF-7
cells (Additional file 8: Figure S6). In this application, Halo-
Tag provided an effective means of covalently linking the
Figure 1 Design of the combinatorial PTM histone peptide microarray. (A) Construction of the combinatorial PTM peptide library.
Combinatorial PTM histone peptide microarray featuring a tiled design and a high content of linked PTMs. Peptide sequence (underlined) covers
core histones and histone variants; colored amino acids were modified according to the key. Colored arcs represent new PTM combinations and
black arcs display PTM combinations used in previous arrays. (B) Histone peptide microarray binding assay. Peptides from Figure 1A were
synthesized as cellulose conjugates and spatially spotted onto microarray, on which reader binding was detected and quantified by dual-channel
fluorescence. Red star represents the binding signal at 635 nm, which was used for reference binding intensities. (C) Layout of the combinatorial
PTM histone peptide microarray. On the left is a representative image of an entire microarray before protein binding (detected at 532 nm, green
channel). On each microarray, two full libraries were included and each peptide was printed as triplicate spots. On the right is a zoom-in of a
subarray from the big library detected at dual-channel (532 nm/635 nm, green/red channel) after protein binding. On each subarray, biotin
peptides were included as positive controls (boxed in red dashed line). Misprinting (boxed in white dashed line) can be easily identified from the
green channel. Protein bindings (boxed in yellow dashed line) were quantified from the signal intensities at 635 nm.
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washing [36]. By Western blot analysis, MARCC revealed
specific enrichment with each reader domain (Figure 4A,B):
ING2-PHD enriched for H3K4me3-containing nucleo-
somes, AIRE-PHD discriminated against H3K4me3, and
ATRX-ADD enriched H3K9me3-containing chromatin. To
further define the chromatin states captured by MARCC,sufficient quantities of histone protein are required for
quantitative mass spectrometry (qMS) while maintaining
the native state of nucleosomes during enrichment. For
this purpose, resin-captured nucleosomes from MARCC
were released with tobacco etch virus (TEV) protease
(Additional file 9: Figure S7) and analyzed by qMS. Owing
to the low abundance of H3K4me3 (<0.1%) in the input
Figure 2 Histone peptide microarray analysis reveals high selectivity for amino-acid sequence and combinatorial PTM states by
recombinant reader domains. (A-C) Heat map representation of binding specificity of reader fusions and histone antibodies determined from
histone peptide microarrays. Reader fusions were probed on the slide at concentrations of 10 nM to 500 nM and antibodies were used as
1:10,000 to 1:2,000 dilution. (A) Effect of amino-acid sequence on binding. Averaged fluorescence signal intensities were normalized to the range
between 0 and 1 by the lowest and the highest values of selected peptides for individual array. (B) Effect of combinatorial PTMs on binding.
Averaged signal intensities for peptides with combinatorial PTMs were normalized to those with single modifications of interests as log2 ratio.
(C) Correct N-terminal context is required for H3K9me3 binding by ATRX-ADD. The signal intensities of K9me3-containing peptides that covered
H3 5 to 17 amino acids were quantified and normalized to the highest signals from individual arrays. ATRX-ADD domain was able to bind
H3K9me3 peptides covering H3 1 to 13 aa (A) but not the peptides of H3 5 to 17 aa, whereas the antibody binds to both sequences.
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was below the detection limit for qMS, though the high
enrichment was evident by Western quantification and
qPCR (Figure 4C).
Quantitative mass spectrometry (qMS) revealed unique
nucleosomal PTM signatures of MARCC-enriched chro-
matin with excellent reproducibility (Additional file 10:
Figure S8 B-D). Consistent with their direct binding sites,
MARCC with AIRE-PHD enriched H3K4unmod-contain-
ing chromatin to 90% and MARCC with ATRX-ADD
enriched both unmodified H3K4 and hypermethylated
H3K9 to more than 90% (Figure 4). Importantly, we were
able to identify and quantify other PTM states that wereco-enriched with the targeted PTM states (Figure 4 and
Additional file 11: Table S1). Specifically, ATRX-ADD, but
not AIRE-PHD, enriched H3K79unmod to over 90% and
H4K20me2/3 to ≈ 80%, implying that these two modifica-
tions are more strongly associated with the combination
of H3K4unmod and H3K9me2/3, but not H3K4unmod
alone. In other words, ATRX-ADD captured specific het-
erochromatin state with four coexisting PTM signatures
(H3K4unmod, H3K9me2/3, H4K20me2/3 and H3K79un-
mod), all of which were present at >80% abundance,
suggesting that most of these states exist on both
histone copies within the mononucleosome. Previous
ChIP-sequencing data have correlated H4K20 and H3K9
Figure 3 Specific binding with native mononucleosome library by reader modules in matrix-assisted reader chromatin capture
(MARCC). (A) Scheme of MARCC. Reader domain characterized by peptide microarray is immobilized on resin and incubated with MNase-digested
native mononucleosomes. Enriched nucleosomes are released by TEV protease cleavage and analyzed for coexisting histone PTMs and associated
DNA. See text for details. (B,C) AIRE-PHD, ING2-PHD and ATRX-ADD were immobilized on resin and incubated with native mononucleosomes.
Bound nucleosomes were boiled on beads and separated on 12% SDS-PAGE and probed with corresponding histone antibodies. HaloTag protein was
included as a negative control. Bound nucleosomes were quantified as percentage input. (D) ING2-PHD MARCC enriched for active chromatin. qPCR
for active chromatin marker GAPDH and heterochromatin marker SAT-2 was performed for DNA extracted from MARCC by ING2-PHD and ChIP by
H3K4me3 antibody (ab8580). IgG and HaloTag were used as negative controls for MARCC and ChIP, respectively. The DNA was quantified by input
DNA standard curve and plotted as percentage input.
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two modifications exist within the same nucleosome. One
possibility is that the interaction between the H4K20
methyltransferase Suv4-20 and H3K9me3-binding protein
HP1 [38] bridges the methyltransferase for intranucleo-
somal H4K20 methylation. H4K20 methylation is located
near the basic batch of H4 [39] and might interfere
with Dot1 (H3K79 methyltransferase), explaining the
co-enrichment of H4K20 hypermethylation with unmo-
dified H3K79. Still, the functional importance of these
four PTMs coexisting at the mononucleosome level
needs further investigation. We speculate that this
combination might be enriched for a particular subtype of
heterochromatin.
To support the hypothesis that ATRX-ADD enriched
unique silent chromatin, relative enrichment of additional
PTM signatures was quantified by qMS (Figure 5A). Simi-
lar analyses were performed with AIRE-PHD from theMARCC enrichment (Figure 5B). We observed positive
enrichment of repressive marks by ATRX-ADD, including
H3K9 hypermethylation, H3K27 hypermethylation and
H4K20 hypermethylation (Figure 5A, above x-axis). Con-
sistent with silent chromatin, active marks such as H4
hyperacetylation and H3K36me3 were depleted by ATRX-
ADD (Figure 5A, below x-axis). MARCC also provided
information on less characterized PTMs, for example,
methylations at H3K79 and H3K18. H3K79 methylation
was dramatically depleted using MARCC with ATRX-
ADD, indicating a negative correlation with this specific
heterochromatin state. Strong enrichment of H3K18me1
by ATRX-ADD and AIRE-PHD (Figure 5A,B), which both
strongly prefer H3K4unmod, suggests a role of this PTM
in connection with H3K4unmod.
Finally, qPCR analysis of MARCC-eluted chromatin
revealed highly enriched heterochromatic DNA by ATRX-
ADD (Figure 5C). Collectively, these results suggest that
Figure 4 A unique nucleosomal PTM combination captured by
ATRX-ADD MARCC. Relative amounts of different PTM states for
selected histone peptide fragments from MARCC-enriched
chromatin determined by qMS. Peptide sequence and modified
lysine is labeled in the chart. Different PTM states for the same
peptide sequence are represented by different colors. Relative
quantity of the dominant state is labeled in the pie chart with
unmodified state colored in gray and dimethylated or trimethylated
state colored in red (red encircling lines mark the pooled dimethylation
and trimethylation states). A high level of near stoichiometric
enrichment of 4 PTM states (H3K4unmod, H3K9me2/3, H3K79unmod
and H4K20me2/3) was identified from MARCC with ATRX-ADD. For
AIRE-PHD MARCC, H3K4unmod but not the other three PTM states
was enriched to 90%.
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enriched by ATRX-ADD represents a heterochromatic
nucleosome species. The specificity of the enrichment
and the combinatorial PTM signatures captured using
MARCC with ATRX-ADD corroborates the application
of MARCC as a tool to enrich, identify and quantify
chromatin states with combinatorial PTM patterns and
associated DNA.
Conclusions
In summary, we demonstrate an efficient, quantitative,
reader-based platform for interrogating epigenetic states
of chromatin (Table 1). The workflow involves (i) using
a combinatorial PTM histone peptide microarray to
define reader specificity and suitability for MARCC and
(ii) utilization of MARCC to enrich, identify and quan-
tify unique chromatin states. Utilizing this workflow, wedescribe three different reader domains that can recognize
combinatorial PTM patterns and enrich unique chromatin
states. Histone PTMs and their corresponding DNA asso-
ciated with specific chromatin states are comprehensively
profiled for as few as 107 cells. Future systematic analyses
of uncharacterized or genetically engineered readers will
expand the capacity of MARCC to reveal undiscovered
chromatin states. We envision that reader-based epigenetic
platforms can function as a new paradigm for customizable
chromatin enrichment reagents, avoiding issues of anti-
body variability and specificity.
Methods
Plasmids
Plasmids encoding mouse ING2-PHD (201 to 281) and
human AIRE-PHD1 (293 to 354) were kindly provided
by T Kutateladze (University of Colorado-Denver) and G
Musco (Dulbecco Telethon Institute), respectively. cDNA
encoding human ATRX-ADD (163 to 292) was syn-
thesized (Integrated DNA Technologies, Inc.). A bacterial
expression vector encoding an N-terminal (HQ)5-HaloTag
followed by a TEV protease cleavage site was kindly sup-
plied by Dr. M Slater and Dr. J Hartnett (Promega). A
similar vector (pFN29) is now commercially available
(Promega). ING2-PHD (200 to 280), AIRE-PHD (293 to
354) and ATRX-ADD (163 to 292) were amplified from
the parent vectors and cloned into the (HQ)5-HaloTag
N-terminal vector with SgfI and PmeI sites.
Protein expression and purification
All recombinant (HQ)5-HaloTag fusion proteins and
(HQ)5-HaloTag alone were expressed in BL21 (DE3)
pLysS cells. When OD600nm reached 0.6 to 0.8, expres-
sion was induced by addition of 0.5 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) at 20 to 25°C for 4 hours
or at 18°C overnight. 150 μM ZnCl2 was supplemented
into the media after induction. The cell pellets were
resuspended in 30 mM HEPES, 500 mM NaCl, pH 7.4,
with 1 mM dithiotheritol (DTT), 1 mM phenylmethyl-
sulfonyl fluoride (PMSF), 10 μg/ml leupeptin, 10 μg/ml
aprotinin and 1 mg/ml lysozyme. After agitation at 4°C
for 30 min, the cell resuspension was further lysed by
three mild sonication cycles (20% amplitude; 5 s on; 5 s
off; 1 min total per sonication cycle) with 1/4″ probe
(Thermo Fisher). Clarified lysate supernatant was incu-
bated with Ni-NTA resin (GE Life Sciences) in batches
for 2 h, 4°C. Resin-bound proteins were washed three
times with 30 mM HEPES, 150 mM NaCl, 20 mM
imidazole, pH 7.4, followed by batch elution with 30 mM
HEPES, 150 mM NaCl, 300 mM imidazole, pH 7.4.
Eluents were dialyzed into 30 mM HEPES, 150 mM NaCl,
pH 7.4, supplemented with 3 mM DTT and up to 10%
(v/v) glycerol. After being concentrated in 10 kDa molecu-
lar weight cut-off (MWCO) Amicon (Millipore), protein
Figure 5 (See legend on next page.)
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(See figure on previous page.)
Figure 5 Quantitative profiling of chromatin PTM patterns identifies heterochromatic signature captured by MARCC with ATRX-ADD.
(A,B) Relative PTM enrichment with ATRX-ADD MARCC and AIRE-PHD MARCC. Relative enrichment was represented by log2 of the ratio of
MARCC over input. PTM states above the x-axis were enriched by MARCC, whereas PTM states in the opposite direction were depleted by
MARCC. Error bars were calculated from two separate MARCC-qMS experiments. For the complete qMS data set, refer to Additional file 11: Table S1.
(C) Relative enrichment of heterochromatic DNA (SAT-2) by qPCR obtained from MARCC with ATRX-ADD. ChIP with H3K9me3 antibody (ab8898)
or IgG and HaloTag were included as controls.
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SDS-PAGE followed by Coomassie staining to check pro-
tein purity and integrity (Additional file 1: Figure S1A).
Proteins were aliquoted and stored at −80°C.
Combinatorial PTM histone peptide microarray synthesis
Peptides were synthesized on modified cellulose with a
Respep SL automated synthesizer (Intavis AG, Köln,
Germany). A spotting control cellulose-Cy3 dye con-
jugate was created by simply removing Fmoc from the
celluspot and coupling Cy3 (Lumiprobe, corp.). A blank
celluspot control was created by deprotecting the Fmoc
of the spot and subjecting the paper to the dissolution
conditions. For peptides, the initial coupling consisted of
equimolar amounts of Fmoc-Ala-OH and Boc-Ala-OH
to decrease resin loading and improve synthesis quality.
Each synthesis included peptides with an acid cleavable
rink linker for quality assessment by HPLC and mass
spectrometry (Additional file 12: Table S2). A 20-atom
polyethylene linker (PE) was also included (Novabiochem),
which improved synthesis and protein binding in the
array. A streptavidin control was created by coupling
Fmoc-Glu-(biotinyl-PEG)-OH (Novabiochem). Standard
Fmoc/tBu chemistry was used to create the 13-amino-acid
peptides. Peptide PTMs were introduced as suitably
protected monomers, as described previously [24]. On
completion of the synthesis, the side chain protecting
groups were removed with 82.5% trifluoroacetic acid
(TFA): 5% thioanisole: 5% water: 5% saturated phenol in
dichloromethane: 2.5% ethane dithiol for 90 minutes
(150 μl per spot). The solution was removed and replaced
with 250 μl of 88.5% TFA, 4% trifluoromethanesulfonic
acid, 2.5% triisopropylsilane, 5% water and agitated gently
overnight to dissolve the cellulose. Peptide cellulose conju-
gates were precipitated twice with cold diethyl ether,
allowed to dry for several minutes, and redissolved into
100 μl dimethyl sulfoxide (DMSO).
The arrays were generated by combining 75% cellulose
peptide DMSO solution with 10% cy3 cellulose and 15%
7× saline-sodium citrate (SSC) buffer (1.05 M NaCl,
105 mM sodium citrate). The biotin positive control was
created by using 7.5% of the DMSO peptide stock solu-
tion with 67.5% DMSO in addition to the Cy3 cellulose
conjugate and SSC buffer. Each solution was mixed in
separate wells of 384-well polypropylene plates and spot-
ted in triplicate onto 75 mm× 25 mm nitrocellulose sides(Intuitive Biosciences) with a Gene Machines OmniGrid
Arrayer (Genomic Solutions). The dip time was 0 ms and
the print time varied between 30 and 50 ms. Humidity
and room temperature were controlled between 40% to
60% relative humidity and 20°C to 25°C. A test microarray
was printed and tested with HaloTag only or streptavidin
only as a control to identify non-specific binding peptides,
which were removed for subsequent microarrays (summa-
rized in Additional file 2 and Additional file 12, Table S2).
The final library contained 746 distinct histone peptide
species. On each nitrocellulose slide, two identical libraries
were printed, with each library containing 16 blocks and
an overall number of 2,337 spots. In each block, blank
cellulose spots and biotin peptide spots were included as
negative and positive controls. The physical map of the
peptide array is described in Additional file 2.
Peptide array binding assay
Peptide arrays were handled with care and protected
from light. All solutions were filtered before putting on
the array. Assays were performed with a modified two-
chamber simplex gasket (Intuitive Bioscience). After
tightening the gasket onto the slide surface, the peptide
array was blocked with blocking solution (1 × PBS, 0.05%
Tween-20, pH 7.4, 1% BSA) at 4°C overnight to reduce
non-specific binding.
For reader binding assay
Purified recombinant (HQ)5-HaloTag proteins (10 nM
to 1 μM) were labeled with excessive HaloTag biotin
ligand (Promega) in blocking solution and incubated
with the peptide array under mild rocking at 4°C for
1 hour. The slide was washed with PBS with 0.05%
Tween (PBST) three times and incubated with 1:2,000
streptavidin-conjugated Alexa-Fluor647 (Invitrogen) in
blocking solution at room temperature for 1 hour.
For antibody binding assay
Different dilutions (1:10,000 to 1:2,000) of rabbit pri-
mary polyclonal antibodies (H3K9me3 antibody ab8898
lot#GR102573-1, H3K4me3 antibody ab8580 lot#GR56122-
1) in blocking solution were incubated with the array under
mild rocking at 4°C for 1 hour. The slide was washed with
PBST three times and incubated with 1:1,000 anti-rabbit
IgG Alexa 647 (Cell Signaling) in blocking solution at
room temperature for 1 hour.
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After three washes in PBST and a final wash in distilled
water, the slide was dried by centrifugation and imaged
at dual wavelengths of 532 nm and 635 nm on Axon
GenePix 4000B (Molecular Devices). The laser power
was set to 100%, with automatic gain adjustment (0.05%
saturation tolerance) for dual photomultipliers. Image
was obtained at 5 μm pixel resolution. Features in each
block were defined by manual adjustment of 13 × 13 grid
(feature diameter, 280 μm; column spacing and row
spacing, 320 μm) to cover every spot. Signal intensities
were quantified by GenePix Pro 6.1 software (Molecular
Devices). For each spot (feature), the mean intensities
for 635 nm wavelength were used for subsequent ana-
lysis. For each peptide species, an average was calculated
from three replicate spots. The averaged intensities were
normalized to the range between 0 and 1 by the lowest
and highest values of selected peptides on each library.
For comparison between peptides with combinatorial
modifications, the intensities were normalized to the
peptide with single modification as log2 ratio. Heat maps
were generated by Java Treeview version 1.1. The signal
at 532 nm wavelength was used to identify misprinting
events. For a complete dataset, see Additional file 3.
Nucleosome reconstitution and MLA (methyl lysine analog)
production
Methyl lysine analog (MLA), H3Kc4me3 (Kc = aminoethyl
cysteine), was prepared according to the literature [40].
Briefly, Histone H3 (Xenopus laevis) with K4C and C110A
mutations was expressed in Escherichia coli and purified
by Superdex200 column followed by ion-exchange col-
umns. The purified histone was reduced, and the cysteine
residue was alkylated with excess (2-bromoethyl) trime-
thylammonium bromide (Sigma Aldrich) at elevated
temperature. After the reaction was quenched with 2-
mercaptoethanol, excess reagents and salts were removed
using a PD-10 desalting device. Along with other core
histones (H2A, H2B, and H4) that are recombinantly
prepared, H3Kc4me3 MLA was refolded into histone octa-
mers. The purified octamer and 146-bp DNA fragments
(shown to exhibit strong positioning to the histone octa-
mers) were reconstituted into nucleosome core particle by
a salt-gradient dialysis method described previously [41].
Reader-probe Western blot
HEK293 cells were lysed in radioimmunoprecipitation
assay (RIPA) buffer with protease inhibitors, nicotinamide
and trichostatin A. The protein level was quantified by
Bradford assay. 10 μg total cell lysates were separated
using 12% SDS-PAGE and transferred to polyvinylidene
fluoride (PVDF) membrane. After blocking with 5% BSA
for 1 hour at room temperature, the membrane was incu-
bated with 100 nM HaloTag ATRX-ADD at 4° for 3 hours.Before incubation, ATRX-ADD was reacted with HaloTag
ligand (biotin conjugate or AlexaFluor 660 conjugate)
(Promega). For biotin conjugate, the membrane was fur-
ther incubated with streptavidin-AlexaFluor647 conjugate
(Invitrogen) at room temperature for 1 hour. After three
washes, the membrane was directly exposed at Cy5 setting
(GE ImageQuant LAS 4000).
Native mononucleosome isolation from MCF-7 cells
MCF-7 cells were cultured in DMEM supplemented
with 10% FBS. For each nucleosome isolation, MCF-7
cells at ≈ 90% confluency from two 10-cm plates (≈2 × 107
cells in total) were collected and washed for three times in
ice-cold Buffer M (10 mM HEPES, 10 mM KCl, 1.5 mM
MgCl2, 340 mM sucrose, pH 7.9, 10% glycerol, v/v),
supplemented with 1 μg/ml trichostatin A, 1 mM DTT,
0.5 mM PMSF, 10 mM β-glycerophosphate, 1 mM leu-
peptin, and 1 mM aprotinin. At the last wash, the cell
resuspension was lysed with 0.1% Triton X-100 on ice for
10 min. After lysis, nuclei pellets were resuspended in
Buffer M and centrifuged at 1,300 g for 12 min through
chilled sucrose cushion buffer (10 mM HEPES, pH 7.9,
30% sucrose, w/v, 1.5 mM MgCl2) to further purify the
nuclei pellets. After three washes with Buffer M, nuclei
was diluted to 1.2 to 1.6 mg/ml DNA concentration and
digested with 2,000 gel units of micrococcal nuclease
(New England Biolabs) at 37°C for 12 min with constant
mixing in the presence of 1 mM final concentration of
CaCl2. Prior to assay, the amount of enzyme and digestion
time was optimized to obtain above 90% purity of mono-
nucleosomes. MNase activity was stopped with 10 mM
ethylenediaminetetraacetic acid (EDTA) and spun down.
Soluble chromatin from the supernatant (S1) was collec-
ted. Less soluble chromatin (S2) was recovered from the
nuclei pellets resuspended in 5 mM HEPES, 0.2 mM
EDTA at 4°C overnight. Pooled chromatin extract (S1 plus
S2) was concentrated to ≈ 10 μM and dialyzed into
30 mM HEPES, 150 mM NaCl, pH 7.4, 10% (v/v) glycerol.
Nucleosomes were analyzed on 1.2% agarose gel (with
0.1% sodium dodecyl sulfate (SDS) in the sample) and
18% SDS-PAGE to check the size and quantity of DNA
and histones separately (Additional file 1: Figure S1). A
yield of ≈ 2 nmole mononucleosomes (or 200 μg DNA)
was usually obtained from a single isolation.
MARCC (matrix-assisted reader chromatin capture)
The MARCC resins were prepared by incubation of
saturating amounts (more than 10 nmole) of purified
recombinant (HQ)5-HaloTag proteins with 200 μl Halo-
Link resin slurry (Promega) in MARCC buffer (30 mM
HEPES, 150 mM NaCl, pH 7.4, 0.01% NP-40, 10%
glycerol) at 4°C for 1 hour. (HQ)5-HaloTag protein alone
was included as a negative control. Excessive proteins
were removed by three brief washes with MARCC buffer.
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native mononucleosomes or reconstituted nucleosomes
with MARCC resins under constant rotation at 4°C over-
night. Bound chromatin was further washed with MARCC
buffer and eluted by Halo-TEV protease (Promega) cleav-
age in the presence of 150 μl 1 mM Tris-HCl, pH 7.4 at
room temperature for 2 hours. Eluted chromatin was
combined with another 150 μl resin-recovered chromatin
and could be used for downstream analysis. For small-
scale enrichment, 100 pmole nucleosomes and 20 μl
MARCC resin were used.Native chromatin immunoprecipitation (NChIP)
100 pmole native mononucleosome extract was mixed
with 2 μg antibody (H3K4me3 - Ab8580, lot# GR56122-1;
H3K9me3 - Ab8898, lot# GR102573-1; normal rabbit
IgG - sc2027) and incubated with 20 μL Magna ChIP
Protein G magnetic beads (Millipore) in buffer N
(30 mM HEPES, 150 mM NaCl, pH 7.4, 0.01% NP-40,
5 mM EDTA) under constant rotation at 4°C overnight.
Bound chromatin was further washed with buffer N three
times and eluted twice with 150 μl elution buffer contain-
ing 1% SDS.Quantitative mass spectrometry for histone PTMs
Procedures for quantitative mass spectrometry sample
preparation and data analysis were as previous described
[42,43]. Briefly, histones were subjected to chemical
derivatization using propionic anhydride (Sigma-Aldrich)
and digested with sequencing grade trypsin (Promega) at a
10:1 substrate to enzyme ratio for 6 hours at 37°C. The
digested peptides were treated with an additional round of
propionylation for the purpose of adding propionyl
group to the newly generated N-terminus. Peptides
were desalted using C18 extracted mini disk (Empore
3 M, MN, USA) and dissolved in 0.1% formic acid.
Approximately 1 μg of each sample was loaded via an
autosampler (EASY-nLC, Thermo Fisher Scientific Inc.)
onto a Thermo Scientific Acclaim PepMap 100 pre-
column (75 μm× 2 cm, C18 resin, 3 μm particle size,
100 Å pore sizes). Peptides were chromatographically
resolved via an Acclaim PepMap rapid separation liquid
chromatography (RSLC) analytical column (50 μm×
15 cm, C18 resin, 2 μm particle sizes, 100 Å pore sizes),
using a 67-min 1-98% solvent B gradient (solvent A = 0.1%
formic acid, solvent B = 100% acetonitrile) at a flow rate of
300 nl/min. The eluted peptides were electrosprayed into
and detected by a Q Exactive mass spectrometer (Thermo
Fisher Scientific Inc.) with a resolution of 70,000 for full
MS spectrum followed by MS/MS spectra obtained in a
higher-energy collisional dissociation cell. The relative
abundance of each modification, expressed as a per-
centage on a histone peptide sequence, was quantified byanalyzing its MS and MS/MS spectra via a program devel-
oped in-house. All results were also manually verified.
DNA isolation and real-time PCR
DNA was isolated from chromatin enriched by MARCC
or NChIP along with 10% input chromatin using GeneJet
PCR purification kit (Fermentas) in the presence of
isopropanol. Real-time PCR was performed in duplicate
with SsoFast EvaGreen supermix (Bio-Rad) on CFX96
(Bio-rad). For each specific PCR primer set, a standard
curve was created from a serial dilution covering 0.2 to 5%
of input DNA. For linear regression, Ct (cycle threshold)
values were plotted with log starting quantity. Primer sets
with R2 over 0.99 and amplification efficiency over 90%
were chosen
efficiency ¼ 10ð1=slopeÞ  1
Nuclease-free water was used as a no-template control
to monitor contaminants interfering with reactions. To
quantify a specific DNA fragment in enriched chromatin
samples, individual Ct values were converted into starting
DNA quantity using corresponding standard curve and
the average was calculated from two individual MARCC
or ChIP experiments.





3) Chr1 SAT2-forward: 5′-CATCGATGGAAATG
AAAGGAGTC-3′;
4) Chr1 SAT2-reverse: 5′- ACCATTGGATGATTG
CAGTCAA-3′.
Additional files
Additional file 1: Figure S1. Probing histone-binding specificities of
reader domains by histone peptide microarray. (A) Construction of
recombinant reader domains. All readers (ING2-PHD, AIRE-PHD1 and
ATRX-ADD) were expressed with N-terminal (HQ)5-HaloTag (HH for short)
with a TEV protease cleavage site. (B) Purification of recombinant reader
domains. Purified proteins were separated on 12% SDS-PAGE before
staining with Coomassie blue.
Additional file 2: Complete list of peptides and microarray layout.
This Excel file contains a complete list of peptides (sequence and PTM
states) and a physical map of the combinatorial histone peptide library.
The same color code is used for sequence coverage as in Figure 1: H3 in
red, H4 in yellow, H2B in green, H2A in blue and H1 in purple. PTM states
are color-coded: methylation in green, acetylation in red, phosphorylation
in orange, and citrullination in purple. The peptides crossed out represent
peptides that were removed from the library owing to non-specific
interactions determined in a preliminary experiment. As shown in the
peptide array map, two libraries were included on each array. The map
corresponds to the layout in Figure 1 and Additional file 4: Figure S2.
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contains the fluorescence signals from peptide microarray binding
experiments. Raw signals and normalized intensities at 635 nm are
included for specified concentrations of reader domains or histone
antibodies from individual experiments. Average and standard deviations
are derived from triplicate spots in each library (— means that signal
cannot be detected due to misprinting). The normalized values used to
generate heat maps are also included.
Additional file 4: Figure S2. Histone peptide microarray images
showed comparison of histone-binding specificity by reader modules
and histone antibodies. The images were selected from representative
arrays. 500 nM purified HH-ATRX-ADD (A), 1:10,000 diluted H3K9me3
antibody (B), 10 nM purified HH-ING2-PHD (C) or 1:10,000 diluted
H3K4me3 antibody (D) were incubated with histone peptide array. The
green channel signal (532 nm) for Cy3 tracer dye was used to identify
misprinting (boxed in white dashed line). The red channel signal
(635 nm) of Alexa647 was used to quantify binding intensities. Both
primary targets and off-targets were boxed and labeled on the image.
For peptide array design and mapping, refer to Additional file 2.
Additional file 5: Figure S3. Specific amino-acid sequence and
combinatorial PTM pattern recognized by reader domains. The signal
intensities were quantified from the images from Additional file 3 scanned
at 635 nm by Axon GenePix 4000B. Signal intensities were averaged from
three replicate spots for the same peptide and normalized to the highest
signal on individual array. Peptides covered selective sites of interests with
combinations of primary PTMs (colored red in the sequence) and secondary
PTMs on nearby residues (colored green in the sequence).
Additional file 6: Figure S4. ATRX-ADD exhibited specific binding
with MLA reconstituted nucleosomes. (A) Reconstituted nucleosomes
with wildtype H3 (wildtype) or nucleosomes harboring H3K4C-me3 or
H3K9C-me3 MLA modifications were probed with H3K4me3 or H3K9me3
antibodies, or Coomassie stained. (B) HaloTag-ATRX-ADD was immobilized
on HaloLink resin and incubated with reconstituted nucleosomes. After
several washes, bound nucleosomes were boiled on beads, separated using
12% SDS-PAGE and probed with H3 C-term antibody (ab46765). HaloTag
protein was included as a negative control. Bound nucleosomes were
compared with 10% input for each species of nucleosomes.
Additional file 7: Figure S5. H3-specific binding of ATRX-ADD from cell
lysate. In a standard Western blot procedure, 10 μg of two separately
prepared HEK293 cell lysates were separated using 12% SDS-PAGE and
transferred to a PVDF membrane. After blocking the membrane with
5% BSA, 100 nM HH-ATRX-ADD (labeled with HaloTag ligand-biotin as in
Figure S5A, or labeled with HaloTag ligand-Alexa 660 as in Figure S5B)
was incubated with the membrane at 4° for 3 hours. (B) After several
washes, the membrane was directly detected at Cy5 setting
(GE ImageQuant LAS 4000). For Figure S5A, the membrane was
further incubated with 1:2000 streptavidin-Alexa647 at room temperature
for 1 hour before detected at Cy5 setting. For comparison, traditional
antibody-based Western blot was performed with 1:5,000 anti-H3K9me3
(ab8898) with 1:5,000 goat-anti-rabbit-HRP, detected by SuperSignal West
Dura kit (Pierce) (Figure S5C).
Additional file 8: Figure S6. Preparation of native mononucleosome
library. (A) Schematic illustration of native mononucleosome library
preparation. Cells were pelleted and lysed to isolate nuclei. Nuclei were
then digested by micrococcal nuclease to generate mononucleosomes in
the soluble fractions. (B,C) Preparation of mononucleosome library by
MNase digestion. Nuclei were digested with MNase and the reaction was
stopped at different time points (0, 1, 3, 6, 9 and 12 min) by addition of
EDTA. The digested chromatin was supplemented with 0.1% SDS (w/v,
final) and run on 1.2% agarose gel at 2 V/cm for 6 hours before staining
with ethidium bromide. S1: soluble fraction 1; S2: soluble fraction 2; P:
precipitation. After 12 min, the pooled soluble fractions (S1 + S2) were
mostly mononucleosomes (>95%). (D) Protein purity and reproducibility
of native mononucleosome library preparations. Two independent
preparations of native MCF-7 mononucleosome library were run on 18%
SDS-PAGE gel and stained with Coomassie blue.
Additional file 9: Figure S7. Preparation, capture and elution of
customized MARCC resin. (A) Release of reader domains by TEV cleavageon resin. ATRX-ADD domain was cleaved off the resin by incubating
immobilized HH-ATRX-ADD with HaloTEV protease. FT, flow-through; E1,
elution 1; E2, elution 2; bead, resin after elution. (B,C) Elution by TEV
cleavage yields intact mononucleosomes for downstream analysis.
Histones (B) and DNA (C) were resolved on gel. Glycine elution did not
achieve similar elution efficiency to TEV cleavage. (D) DNA purified from
AIRE-PHD, ING2-PHD and ATRX-ADD MARCC enrichment was run on 1%
agarose gel. The DNA size was enriched at 146 bp.
Additional file 10: Figure S8. MARCC-enriched chromatin reveals
coexisting PTM patterns. (A) Peptide sequence coverage with associated
PTMs of qMS used in this study. (B) Comparison of input chromatin
used in this study with previous dataset [44]. (C,D) Reproducibility of
qMS quantifications for MARCCs by AIRE-PHD and ATRX-ADD. Linear
correlation of the same peptide species from two independent
MARCC-qMS assays were calculated.
Additional file 11: Table S1. Quantitative assessment of combinatorial
histone PTM patterns by MARCC-qMS.
Additional file 12: Table S2. Quality control data for peptides from
peptide microarray.Abbreviations
AIRE: autoimmune regulator; ATRX: alpha-thalassemia/mental retardation,
X-linked; ADD: ATRX-DNMT3-DNMT3L; BSA: bovine serum albumin;
ChIP: chromatin immunoprecipitation; Ct: cycle threshold; DMEM: Dulbecco’s
modified Eagle’s medium; DMSO: dimethyl sulfoxide; DTT: dithiotheritol;
EDTA: ethylenediaminetetraacetic acid; FBS: fetal bovine serum;
H3K4me3: histone H3 trimethylated at lysine 4; H3K9me3: histone H3
trimethylated at lysine 9; HH: (HQ)5-HaloTag; HPLC: high-performance liquid
chromatography; IgG: immunoglobulin G; ING: inhibitor of growth;
IPTG: isopropyl β-D-1-thiogalactopyranoside; Kc: aminoethyl cysteine;
MARCC: matrix-assisted reader chromatin capture; MCF-7: Michigan
Cancer Foundation-7; MLA: methyl lysine analog; MNase: micrococcal
nuclease; MS: mass spectrometry; MWCO: molecular weight cut-off;
NChIP: native chromatin immunoprecipitation; OD: optical density;
PBS: phosphate-buffered saline; PBST: phosphate-buffered saline with
Tween; PCR: polymerase chain reaction; PE: polyethylene linker;
PHD: plant homeodomain; PMSF: phenylmethylsulfonyl fluoride;
PTM: post-translational modification; PVDF: polyvinylidene fluoride;
qMS: quantitative mass spectrometry; qPCR: quantitative polymerase
chain reaction; RSLC: rapid separation liquid chromatography;
SDS: sodium dodecyl sulfate; SSC: saline-sodium citrate; TEV: tobacco
etch virus; TFA: trifluoroacetic acid.
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